Vanda Pharmaceuticals (VNDA) came out with a quarterly loss of $0.38 per share versus the Zacks Consensus Estimate of a loss of$0.31. This compares to a loss of $0.09 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -22.58$0.34 per share when it actually produced a loss of $0.46, delivering a surprise of -35.29%.Over the last four quarte ...